Cadrenal Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $2.55-$14.64 |
Market Cap | $9.4M |
Shares Short | 68,650 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$5.59 |
News
See moreYahoo Finance • 7 days ago
Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease
Yahoo Finance • 10 days ago
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
Yahoo Finance • 3 months ago
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
About
CEO | Mr. Quang X. Pham |
CFO | Mr. Quang X. Pham |
Address | 822 A1A North, Ponte Vedra, FL, United States, 32082 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |